Marco Wachtel

10PUBLICATIONS
153CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Aug 21, 2025
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

Willemijn Breunis, Eva Brack, Anna C Ehlers

|Jul 26, 2024
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma.

Sara G Danielli, Yun Wei, Michael A Dyer

|Apr 13, 2024
Functional Classification of Fusion Proteins in Sarcoma.

Marco Wachtel, Didier Surdez, Thomas G P Grünewald

|Mar 12, 2024
Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer.

Sara G Danielli, Jakob Wurth, Sarah Morice

|Dec 30, 2023
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models.

Fabian F Pusch, Heathcliff Dorado García, Robin Xu

Pageof 2

Frequent Collaborators

10 joint publications

Beat W Schäfer

5 joint publications

Didier Surdez

3 joint publications

Sara G Danielli

3 joint publications

Olivier Delattre